Low-Dose r-ATG vs Basiliximab in Low-Risk Living-Donor Kidney Transplantation: Outcomes in Acute Rejection, Graft Function, and Infections
Annals of Transplantation · 2025
DOI: 10.12659/aot.949942 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Annals of Transplantation, 2025. Verfasst von Nam Ho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Surgical and Transplant Intensive Care Unit, Military Central Hospital 108, Hanoi, Vietnam. Hauptthemen laut MEDLINE: Kidney Transplantation, Basiliximab, Graft Rejection, Antilymphocyte Serum. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Surgical and Transplant Intensive Care Unit, Military Central Hospital 108, Hanoi, Vietnam.
- Institute of Biomedicine and Pharmacy, Vietnam Military Medical University, Hanoi, Vietnam.
- College of Health Sciences, Vin University, Hanoi, Vietnam.
ORCID-Profile: Nam Ho, Chi Tam Nguyen
Zitieren
APA
Ho, N., Nguyen, T. T., Do, N. V., Nguyen, C. T., Hoang, S. X., Hoang, K. V. N., & Ngo, T. D. (2025). Low-Dose r-ATG vs Basiliximab in Low-Risk Living-Donor Kidney Transplantation: Outcomes in Acute Rejection, Graft Function, and Infections. Annals of Transplantation. https://doi.org/10.12659/aot.949942
Vancouver
Ho N, Nguyen TT, Do NV, Nguyen CT, Hoang SX, Hoang KVN, et al. Low-Dose r-ATG vs Basiliximab in Low-Risk Living-Donor Kidney Transplantation: Outcomes in Acute Rejection, Graft Function, and Infections. Annals of Transplantation. 2025. doi:10.12659/aot.949942
BibTeX
@article{Ho2025,
author = {Ho, Nam and Nguyen, Thu Thi and Do, Nam Van and Nguyen, Chi Tam and Hoang, Su Xuan and Hoang, Khanh Vo Ngoc and Ngo, Trung Dinh},
title = {Low-Dose r-ATG vs Basiliximab in Low-Risk Living-Donor Kidney Transplantation: Outcomes in Acute Rejection, Graft Function, and Infections},
journal = {Annals of Transplantation},
year = {2025},
doi = {10.12659/aot.949942}
}
EUVIMED